Cargando…

Effect of a SARS-CoV-2 booster vaccine dose on the immune response of adults with Down syndrome

Detalles Bibliográficos
Autores principales:	Yarci-Carrión, Ayla, Esparcia-Pinedo, Laura, Mateo-Jiménez, Gloria, Alfranca, Arantzazu, de Asúa, Diego Real, Gutiérrez-Cobos, Ainhoa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675634/ https://www.ncbi.nlm.nih.gov/pubmed/36417985 http://dx.doi.org/10.1016/j.jinf.2022.11.014

Ejemplares similares

Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination
por: Esparcia-Pinedo, Laura, et al.
Publicado: (2022)

Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer
por: Esparcia-Pinedo, Laura, et al.
Publicado: (2023)

Factor associated with SARS-CoV-2 vaccination serological efficacy in adolescents and adults with Down syndrome: Data from an international, collaborative initiative of the Trisomy 21 Research Society
por: Valentini, D., et al.
Publicado: (2023)

Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs
por: Meca-Lallana, Virginia, et al.
Publicado: (2023)

Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
por: Gutiérrez-Cobos, Ainhoa, et al.
Publicado: (2020)

A Cross-Sectional Study of the Phenotypes of Obesity and Insulin Resistance in Adults with Down Syndrome
por: Real de Asua, Diego, et al.
Publicado: (2014)

CD4+ T Cell Immune Specificity Changes After Vaccination in Healthy And COVID-19 Convalescent Subjects
por: Esparcia-Pinedo, Laura, et al.
Publicado: (2022)

Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
por: Chavda, Vivek P., et al.
Publicado: (2022)

Comparison of the Effectiveness and Safety of Heterologous Booster Doses with Homologous Booster Doses for SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis
por: Deng, Jie, et al.
Publicado: (2022)

Evaluation of congenital and acquired heart diseases in a Spanish cohort of adults with Down syndrome
por: Rabes, Laura, et al.
Publicado: (2022)

Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy
por: Dick, Aharon, et al.
Publicado: (2022)

Lessons from individuals with Down syndrome during COVID-19
por: del Carmen Ortega, María, et al.
Publicado: (2020)

RGB-Marking to Identify Patterns of Selection and Neutral Evolution in Human Osteosarcoma Models
por: Gambera, Stefano, et al.
Publicado: (2021)

Extracellular Vesicle-Mediated Immune Regulation of Tissue Remodeling and Angiogenesis After Myocardial Infarction
por: Sánchez-Alonso, Santiago, et al.
Publicado: (2018)

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
por: Kuhlmann, Constanze, et al.
Publicado: (2022)

Effectiveness of Booster Doses of the SARS-CoV-2 Inactivated Vaccine KCONVAC against the Mutant Strains
por: Xiao, Chanchan, et al.
Publicado: (2022)

Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
por: Tung, Tao-Hsin, et al.
Publicado: (2022)

Safety and Immunogenicity of Anti-SARS-CoV-2 Booster Dose in Patients with Chronic Liver Disease
por: Cossiga, Valentina, et al.
Publicado: (2023)

Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2
por: Hertz, Tomer, et al.
Publicado: (2023)

Principales modifications booster au shut down - 1974-75
por: Delahaye, J P
Publicado: (1975)

SARS-CoV2 vaccine boosters for India
por: Kang, Gagandeep
Publicado: (2022)

A Study on the Relationship between Serum Beta 2-Microglobulin Levels, Underlying Chronic Kidney Disease, and Peripheral Arterial Disease in High-Vascular-Risk Patients
por: Real de Asúa, Diego, et al.
Publicado: (2012)

Triage criteria for cardiopulmonary resuscitation and advanced life support during the COVID-19 epidemic()
por: Real de Asúa, Diego, et al.
Publicado: (2020)

Criterios de triaje para reanimación cardiopulmonar y soporte vital avanzado durante la epidemia COVID-19
por: Real de Asúa, Diego, et al.
Publicado: (2020)

The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2021)

Immune response of booster doses of BBIBP-CORV vaccines against the variants of concern of SARS-CoV-2
por: Mahmoud, Sally, et al.
Publicado: (2022)

Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients – targeting the target antigen
por: Uyemura, Bradley S., et al.
Publicado: (2022)

P-159: Effectiveness of anti-SARS-CoV-2 vaccine “booster” dose in patients with multiple myeloma
por: Sgherza, Nicola, et al.
Publicado: (2022)

Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2
por: Voutouri, Chrysovalantis, et al.
Publicado: (2023)

Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis
por: Zhan, Haoting, et al.
Publicado: (2023)

Booster Doses and Prioritizing Lives Saved
por: Patel, Minal K.
Publicado: (2021)

Prevertebral Inflammatory Myofibroblastic Tumor Following COVID Vaccine Booster Dose
por: Sprenger, Flávia, et al.
Publicado: (2023)

SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines
por: Di Giacomo, Anna M., et al.
Publicado: (2022)

Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
por: Jaggaiahgari, Shashidhar, et al.
Publicado: (2022)

Bilateral Branch Retinal Vein Occlusion after mRNA-SARS-CoV-2 Booster Dose Vaccination
por: Gironi, Matteo, et al.
Publicado: (2023)

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
por: Özbay Kurt, Feyza Gül, et al.
Publicado: (2022)

Booster effect of the third dose of SARS-CoV-2 mRNA vaccine in Japanese kidney transplant recipients
por: Kawabe, Mayuko, et al.
Publicado: (2023)

Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome
por: Real de Asua, Diego, et al.
Publicado: (2021)

Oral booster probiotic bifidobacteria in SARS-COV-2 patients
por: Bozkurt, Hüseyin S, et al.
Publicado: (2021)

Antibody response to SARS-CoV-2 booster vaccines
por: Loving, Hanna S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7i5n9oad8t4ff2kt96067socm9